Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-22-007925

President and CEO bought 5,250 shares at $1.38 ($7,245)

From the SEC's structured data for this filing

Trades in this filing

Culley Brian M · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-03-25 Purchase : show line 1 in the form +5,250 $1.38 $7,245 81,280 D
Open-market purchases · 5,250 sh · avg $1.38 · $7,245
Loading xslF345X03/ownership.xml…